Click on the “Search Now” button to search for research studies enrolling people like you. Need help getting started? Click on “Tips for Searching Studies” to find resources and assistance to help you find studies.
A Study to Compare Two Surgical Procedures in Women with BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer (SOROCk)
Clinicaltrials.gov identifier:
NCT04251052
Prevention:
Ovarian
TALAPRO-2: A Study Assessing the Study Drug + Enzalutamide vs. Placebo + Enzalutamide in Men With Metastatic Castration Resistant Prostate Cancer (mCRPC) and DNA Damage Repair (DDR) Deficiency
Clinicaltrials.gov identifier:
NCT03395197
Treatment:
Prostate
PARP Inhibitor Alone or Plus Immunotherapy for Advanced BRCA-Associated Breast Cancer
Clinicaltrials.gov identifier:
NCT02849496
Treatment:
Breast
A Randomized Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Breast, Ovarian, Prostate and Pancreatic Cancer Patients (E-Reach)
Treatment:
Breast, Ovarian, Pancreatic, Prostate
Denosumab in BRCA1 or BRCA2 Mutation Carriers Scheduling Risk-Reducing Salpingo-Oophorectomy
Clinicaltrials.gov identifier:
NCT03382574
Prevention:
Ovarian
Men at High Genetic Risk for Prostate Cancer
Clinicaltrials.gov identifier:
NCT03805919
Prevention:
Prostate
Genetic Testing for Men with Metastatic Prostate Cancer (GENTleMEN Study)
Clinicaltrials.gov identifier:
NCT03503097
Treatment:
Prostate
PARP Inhibitor for Metastatic Breast Cancer with an Acquired BRCA1 or BRCA2 Mutation Found by Liquid Biopsy
Clinicaltrials.gov identifier:
NCT03990896
Treatment:
Breast
Olaparib Expanded - Treating Metastatic Breast Cancer in People without gBRCA Mutations
Clinicaltrials.gov identifier:
NCT03344965
Treatment:
Breast
Pathways to Wellness
Clinicaltrials.gov identifier:
NCT03025139
Quality of Life:
Breast Cancer Survivor
Studying a Combination of Immunotherapies and Biomarker for Advanced Solid Tumors
Clinicaltrials.gov identifier:
NCT03668119
Treatment:
Breast, Ovarian, Pancreatic, Prostate
CheckMate-9KD for Men with Metastatic Prostate Cancer
Clinicaltrials.gov identifier:
NCT03338790
Treatment:
Prostate
ATHENA - Rucaparib and Nivolumab for Maintenance in Ovarian Cancer
Clinicaltrials.gov identifier:
NCT03522246
Treatment:
Ovarian
Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth
Clinicaltrials.gov identifier:
NCT03327103
Treatment:
Prostate
Quality of Life:
Prostate Cancer Survivor
PARP Inhibitor for Metastatic Prostate Cancer With DNA Repair Defects
Clinicaltrials.gov identifier:
NCT03012321
Treatment:
Prostate
.jpg)
Immunotherapy and PARP Inhibitor Combo for Advanced Cancers Caused By a BRCA or ATM Mutation
Clinicaltrials.gov identifier:
NCT03565991
Treatment:
Breast, Ovarian, Pancreatic
Olaparib Plus DNA Damage Repair Targeted Therapy for Metastatic TNBC
Clinicaltrials.gov identifier:
NCT03330847
Treatment:
Breast
Olive Oil for High Risk Breast Cancer Prevention
Clinicaltrials.gov identifier:
NCT02068092
Pancreatic Cancer Screening Study for High Risk People
Clinicaltrials.gov identifier:
NCT03250078
Prevention:
Pancreatic
Acupressure to Self-Manage Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors
Clinicaltrials.gov identifier:
NCT03697200
Quality of Life:
Breast Cancer Survivor
Denosumab and Mammographic Density in Premenopausal Women With Dense Breasts (TRIDENT)
Clinicaltrials.gov identifier:
NCT04067726
Prevention:
Breast
A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)
Clinicaltrials.gov identifier:
NCT03992131
Treatment:
Breast, Ovarian
Study of Safety and Effectiveness of Motiva® Breast Implants
Clinicaltrials.gov identifier:
NCT03579901
Quality of Life:
High Risk But No Cancer, Breast Cancer Survivor
Study for People with Unexpected Genetic Results
Clinicaltrials.gov identifier:
NCT02595957
Prevention:
Breast, Ovarian, Pancreatic, Prostate
A Study to Evaluate Rucaparib in Patients with Solid Tumors and with Deleterious Mutations in HRR Genes
Clinicaltrials.gov identifier:
NCT04171700
Treatment:
Breast, Ovarian, Pancreatic, Prostate
Study Using M6620 (VX-970) An ATR Inhibitor to Treat Solid Tumors
Clinicaltrials.gov identifier:
NCT03718091
Treatment:
Breast, Ovarian, Pancreatic, Prostate, Melanoma
.jpg)
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
Clinicaltrials.gov identifier:
NCT03572374
Quality of Life:
Breast Cancer Survivor
ELLIE's Project
Quality of Life:
High Risk But No Cancer, Breast Cancer Survivor, Ovarian Cancer Survivor, Pancreatic Cancer Survivor, Melanoma Cancer Survivor
IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups
Clinicaltrials.gov identifier:
NCT03693378
Prevention:
Pancreatic
INTERVAL: INTense Exercise foR surVivAL in Men With Metastatic Prostate Cancer
Clinicaltrials.gov identifier:
NCT02730338
Quality of Life:
Prostate Cancer Survivor
RADCOMP: A Study at the Heart of Breast Cancer Treatment
Clinicaltrials.gov identifier:
NCT02603341
Treatment:
Breast
IMPRES - Improving Memory after RRSO
Clinicaltrials.gov identifier:
NCT03187353
Quality of Life:
High Risk But No Cancer, Breast Cancer Survivor, Ovarian Cancer Survivor
TRITON3- Rucaparib vs. Physician Choice for Castration Resistant Prostate Cancer
Clinicaltrials.gov identifier:
NCT02975934
Treatment:
Prostate
Memory Study for BRCA Mutation Carriers
Quality of Life:
High Risk But No Cancer, Breast Cancer Survivor, Ovarian Cancer Survivor, Pancreatic Cancer Survivor, Melanoma Cancer Survivor
Aerobic Training in Post-Menopausal Women at High-Risk for Breast Cancer
Clinicaltrials.gov identifier:
NCT02494869
Prevention:
Breast
.jpeg)
Serum Folate in Patients Treated with Olaparib
Clinicaltrials.gov identifier:
NCT04024254
Treatment:
Breast, Ovarian
Long-Term Survivors of Ovarian Cancer (LTSOC)
Clinicaltrials.gov identifier:
NCT02321735
Quality of Life:
Ovarian Cancer Survivor
ARIEL4: Rucaparib and Recurrent Ovarian Cancer
Clinicaltrials.gov identifier:
NCT02855944
Treatment:
Ovarian
Sponsored By:
